Ask any of the health-focused VCs to call one of many prime AI startups and one identify comes up again and again: an organization primarily based in Pittsburgh referred to as Abridge. And it’s a startup that launched earlier than OpenAI was a family identify and LLMs entered the widespread Valley vocabulary.
In 2019, Shiv Rao, a practising heart specialist, pitched Andy Weissman, basic accomplice at Union Sq. Ventures, on a startup thought. Rao referred to as it SoundCloud plus RapGenius for drugs.
Whereas Weissman thought that evaluating a nascent AI-powered medical notice taking app with music internet hosting and lyrics transcription was a bit humorous, the idea resonated with him.
Rao defined that medical doctors spend as much as two hours a day—sometimes outdoors of standard working hours—typing notes that summarize what was mentioned with their sufferers that day. Such administrative duties have been inflicting doctor burnout for years, main some to depart the occupation altogether. Rao satisfied Weissman that the most recent improvements in AI may dramatically cut back the period of time medical doctors spend on the ever-growing paperwork burden.
This was years earlier than generative AI took the world by storm and captured VCs’ creativeness.
“It was a reasonably wacky thought. Nobody had accomplished it earlier than,” Weissman stated.
However Weissman and different USV companions preferred that Rao was not solely a doctor on the College of Pittsburgh Medical Heart but in addition spent half his time as a company enterprise capitalist for that well being system, investing in well being tech startups. Rao’s workers and advisers have been additionally graduates and professors at Carnegie Mellon, one of many prime establishments within the nation for engineering and AI analysis.
“[Shiv] had this uncommon mixture of skills: an entrepreneur with a really bold imaginative and prescient, with a extremely attention-grabbing staff,” Weissman stated. “It felt distinctive.”
Abridge additionally had a fundamental transcription product, which medical doctors may obtain totally free on their smartphones and begin utilizing throughout their interactions with sufferers. Their utilization fashioned the idea of Abridge’s LLM.
A little bit over 5 years after USV led a $5 million seed spherical into Rao’s startup Abridge, the corporate has turn out to be probably the most talked about and quickly rising AI-powered healthcare companies.
Though most companies are nonetheless very cautious about adopting AI instruments, giant medical programs are wanting to signal contracts with Abridge.
“The gross sales cycle for [health systems] may be 18 to 24 months,” stated Rao. “After we began the corporate, we knew what we have been in for.” However with a four-year lead on a digital scribe product educated on hundreds of doctor-patient conversations, and now that AI is booming, hospitals are all of a sudden shopping for Abridge at a fast tempo, a stark distinction to their sometimes protracted buying conduct. The corporate has introduced a brand new well being system buyer almost each week because the begin of 2024.
“We had constructed up all this potential vitality that turned kinetic virtually in a single day in January,” Rao stated. “College of Chicago, Sutter, Yale, Lee Well being, Christus, Emory and the record goes on and on,” he stated.
Massive hospitals will not be solely shopping for multi-thousand seat licenses of Abridge however, in lots of circumstances, publishing glowing critiques about how the well being tech’s software program is altering physicians’ lives. Hospital executives and medical doctors are describing Abridge as “life-changing,” “magical,” and “probably the most vital paradigm shifts inside our careers.”
One of many greatest criticisms of generative AI is that it nonetheless has few substantive enterprise purposes. However digital medical notice taking appears to be a invaluable utility of the novel expertise.
Drowning in paperwork
“I’ve obtained skilled PTSD and conflict tales about seeing sufferers after which having to spend hours and hours at night time writing notes and doing all this clerical work that actually distracts from the factor that issues most, which is your affected person, but in addition takes away from your individual private life,” Rao stated.
With Abridge recording within the background, a doctor can focus fully on the affected person with out having to fret about filling out particular fields within the medical document in the course of the go to.
The payback of AI-powered medical scribes are very simple to measure, says Dr. Lee Schwamm, chief digital well being officer at Yale New Haven Medical System, an Abridge buyer. That’s why so many well being programs are flocking to make use of them, significantly Abridge. . “It is without doubt one of the hottest merchandise within the AI area in the mean time,” he advised TechCrunch.
As with many administrative issues in well being tech, in relation to choosing a vendor, a very powerful consideration is worth and integration with Epic, an EHR utilized by most giant well being programs within the US, Schwamm stated. Abridge, which helps 14 international languages, together with Haitian Creole, Brazilian Portuguese and Punjabi, is usually the winner when well being programs are doing head-to-head comparisons with different AI-powered medical scribes, Schwamm stated.
Earlier this yr, Abridge gained a proper to be integrated inside Epic. After Abridge data a session and a physician stops the recording, “there’s a notice in English sitting inside Epic ready for them to shortly confirm, edit and modify it as they see match,” Rao stated.
Whereas Abridge seems to be forward of its rivals, which, apart from Microsoft-owned Nuance, embody Ambiance, Nabla and Suki, Schwamm will not be sure will probably be capable of preserve its lead over the long run.
“The massive query is, do you want a devoted medical LLM to achieve success on this area?” he requested. “Or will the enormous basis fashions, GPT-4o, Google and Meta, get so good that they may ingest a whole corpus of medical notes and begin to ship efficiency that’s comparable?”
That line of inquiry exhibits that these are nonetheless early days not only for digital medical notice taking however for many generative AI firms. The tempo of innovation is quick and livid, and as we speak’s winners may simply lose their edge.
“Abridge is forward by a size, nevertheless it’s early within the race,” Schwamm stated, “A horse can get a foul knee and stumble, or it will possibly preserve getting additional and additional forward.”
For now, most buyers TechCrunch talked to agree that Abridge is main the AI-powered medical scribe competitors. Because of this, cash has been pouring into the corporate.
In February, Abridge raised a $150 million Collection C led by Lightspeed Ventures at a valuation of $850 million.